Factors Predicting Human Papillomavirus Vaccination Intention among Men Who Have Sex with Men Receiving Sexual Health Services
Article Sidebar
Main Article Content
Abstract
The descriptive predictive research aimed at identifying significant predictor of human papillomavirus (HPV) vaccination intention among men who have sex with men (MSM) receiving sexual health services from five factors: HPV knowledge, outcome expectations, self - efficacy to get HPV vaccine, self - control to get HPV vaccine and situational perception. Subjects were 140 MSM who came to receiving sexual health services from three places in Bangkok using convenience sampling technique. Data were collected using HPV knowledge questionnaire, outcome expectations questionnaire, self - control to get HPV vaccine questionnaire, situational perception questionnaire, self - efficacy to get HPV vaccine questionnaire and the intention to take human papillomavirus vaccine questionnaire. The questionnaires were tested for their content validity (CVI) by five experts. Their CVIs were 1.00, .87, 1.00, 1.00, 1.00, and 1.00, respectively. Their KR-20 = .82 and Cronbach’s alpha coefficients were .81, .81, .94, .94, and .90, respectively. Data were analyzed using stepwise multiple regression.
The results revealed that: 1. The mean score of intention to take human papillomavirus vaccine was at high level ( = 11.39, S.D = 2.39). 2. Self - efficacy to get HPV vaccine (β = .41), situational perception (β = .23) and HPV knowledge (β = .14) were significant predictors of intention to take HPV vaccine among men who have sex with men receiving sexual health services. These significant predictive variables accounted for 40.10% of the total variance in intention to take HPV vaccine (p-value < .05). However, outcome expectations and self - control to get HPV vaccine could not significantly predict intention to take HPV vaccine (p-value > .05)
Article Details
References
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA: A Cancer Journal for Clinicians 2018;68(1):7-30.
Viens LJ, Henley JS, Watson M, Markowitz LE, Thomas CC, Thompson TD, et al. Human papillomavirus - associated cancers - United States, 2008–2012. Morbidity and Mortality Weekly Report 2016;65(26):61-6.
Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. Journal of the National Cancer Institute 2015;107(6):1-12.
Park IU, Introcaso C, Dunne EF. Human papillomavirus and genital warts: a review of the evidence for the 2015 centers for disease control and prevention sexually transmitted diseases treatment guidelines. Clinical Infectious Diseases 2015;61(8):849-55.
Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. The Lancet Oncology 2012;13(5):487-500.
Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. Morbidity and Mortality Weekly Report 2015;64(11):300-4.
Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Penny ME, Aranda C, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. The New England Journal of Medicine 2011;364(5):401-11.
Phanuphak N, Teeratakulpisarn N, Pankam T, Kerr SJ, Barisri J, Deesua A, et al. Anal human papillomavirus infection among Thai men who have sex with men with and without HIV infection: prevalence, incidence, and persistence. Journal of Acquired Immune Deficiency Syndromes 2013;63(4):472-9.
Goldstone S, Palefsky JM, Giuliano AR, Moreira ED Jr, Aranda C, Jessen H, et al. Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. Journal of Infectious Diseases 2011;203(1):66-74.
U.S. Food and Drug Administration. October 16, 2009 approval letter-gardasil [Internet]. 2009 [cited 2018 May 9]. Available from: http://wayback.archive-it.org/7993/20170722145332/https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186991.htm
Thailand Food and Drug Administration. July 22, 2014 approval human papilloma virus GARDASIL registration No. 1C11/55(NB) [Internet]. 2014 [cited 2018 May 9]. Available from:
Wheldon CW, Daley EM, Buhi ER, Nyitray AG, Giuliano AR. Health beliefs and attitudes associated with HPV vaccine intention among young gay and bisexual men in the southeastern United States. Vaccine 2011;29(45):8060-5.
Priest HM, Knowlden AP, Sharma M. Social cognitive theory predictors of human papillomavirus vaccination intentions of college men at a southeastern university. International Quarterly of Community Health Education 2015;35(4):371-85.
Bandura A. Health promotion by social cognitive means. Health Education and Behavior 2004;31(2):143-64.
Fishbein M, Ajzen I. Predicting and changing behavior: the reasoned action approach. New York: Taylor & Francis; 2011.
Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. American Journal of Transplantation 2019;19(11):3202-6.
Public Health England. HPV vaccination pilot for men who have sex with men: clinical and operational guidance for healthcare professionals [Internet]. 2016 [cited 2019 Feb 20]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/697362/HPV_MSM_clinical_and_operational_guidance.pdf
Cohen J. Statistical power analysis for the behavioral sciences. New Jersey: Lawrence Erlbaum Associates; 1988.
van Keulen HM, Otten W, Ruiter RA, Fekkes M, van Steenbergen J, Dusseldorp E, et al. Determinants of HPV vaccination intentions among Dutch girls and their mothers: a cross- sectional study. BMC Public Health 2013;13:1-21.
Sharma M, Nahar VK. New approach for promoting HPV vaccination in college men based on multi-theory model (MTM) of health behavior change. Journal of Preventive Medicine and Hygiene 2017;58(3):203-10.
Kreupimy S, Thato R. Factors predicting intention to take human papillomavirus vaccine among men who have sex with men students. Kuakarun Journal of Nursing 2016;23(1):102-17. (in Thai)
Marra E, Alberts C, Zimet GD, Paulussen T, Heijman T, Hogewoning A, et al. HPV vaccination intention among male clients of a large STI outpatient clinic in Amsterdam, the Netherlands. Papillomavirus Research 2016;2:178-84.